News
The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...
14hon MSN
Vaccinating young children against Covid-19 may be more challenging this respiratory virus season
Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Hosted on MSN2mon
FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions
The primary efficacy was to demonstrate the vaccine efficacy against COVID-19 starting 14 days after mNEXSPIKE compared with Spikevax, Moderna's updated COVID-19 vaccine approved on Sept. 6, 2024.
Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.
Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...
WASHINGTON — The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results